| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.0M | +260.2% | -12.6% |
| R&D Expense | $12.2M | -24.9% | -17.7% |
| SG&A Expense | $6.3M | -15.0% | -36.1% |
| Pre-tax Income | -$7.5M | — | +31.9% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$7.5M | +68.9% | +34.4% |
| EPS (Basic) | -$1.51 | +69.0% | -1577.8% |
| EPS (Diluted) | -$1.51 | +69.0% | -1577.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.4M | -26.7% | -28.5% |
| Accounts Receivable | $168K | -36.8% | -83.2% |
| Current Assets | $60.0M | -25.1% | -62.6% |
| Total Assets | $62.7M | -25.9% | -63.0% |
| Current Liabilities | $43.3M | -27.1% | -36.6% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$55.1M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $27.8M | — | — |
| Financing Cash Flow | -$24.0M | — | — |
| Free Cash Flow | -$55.1M | — | — |
| $0 |
| — |
| -100.0% |
| Total Liabilities | $122.2M | -11.3% | -27.5% |
| Stockholders' Equity | -$59.5M | -12.0% | -5775.6% |